Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease
Data from the Bezafibrate Infarction Prevention (BIP) Study
Moti Haim, MD* ,*,
David Tanne, MD* ,
Valentina Boyko, MSc* ,
Tamar Reshef, MSc* ,
Uri Goldbourt, PhD* ,
Jonathan Leor, MD* ,
Yoseph A. Mekori, MD* and
Solomon Behar, MD*
* Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Department of Medicine and the Laboratory of Allergy and Clinical Immunology, Meir General Hospital, Kfar-Saba, Israel
Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Hashomer, Israel
Stroke Unit, Sheba Medical Center, Tel-Hashomer, Israel

View larger version (13K):
[in a new window]
|
Figure 1 Distribution of cases (black bars) and controls (white bars) according to soluble intercellular adhesion molecule-1(sICAM-1) concentrations.
|
|
|